Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9517769 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Daclizumab to Treat Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Daclizumab

Indicates status has not been verified in more than two years